York GP Ltd. Purchases New Holdings in Danaher Co. (NYSE:DHR)

York GP Ltd. acquired a new position in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 20,000 shares of the conglomerate’s stock, valued at approximately $4,591,000. Danaher makes up approximately 4.3% of York GP Ltd.’s investment portfolio, making the stock its 2nd biggest holding.

Other hedge funds have also recently bought and sold shares of the company. Fort Pitt Capital Group LLC grew its position in shares of Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after buying an additional 7,421 shares during the period. Good Life Advisors LLC acquired a new stake in Danaher during the 3rd quarter worth $217,000. ORG Partners LLC raised its position in shares of Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after acquiring an additional 2,559 shares during the last quarter. Harvest Portfolios Group Inc. lifted its stake in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares during the period. Finally, Generate Investment Management Ltd bought a new position in shares of Danaher in the 4th quarter worth $8,044,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DHR has been the topic of several analyst reports. Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Wells Fargo & Company cut their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Scotiabank assumed coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Trading Up 0.3 %

Shares of Danaher stock opened at $202.22 on Thursday. The stock has a market cap of $146.06 billion, a P/E ratio of 38.30, a P/E/G ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The business’s 50 day moving average is $230.49 and its 200-day moving average is $250.28.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the company earned $2.09 earnings per share. Equities research analysts predict that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.